Wednesday, July 8, 2026

pharma · Obesity · Obesity With Diabetes · KLRA

Kailera Therapeutics

Kailera Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Waltham, USA HQ
2024 Founded
153 Employees
Public company Type
KLRA · NYSE Ticker
Company details
Intelligence · Clinical Trials

Kailera Therapeutics clinical trials

Registry index of 10 ClinicalTrials.gov studies linked to Kailera Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Kailera Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for Kailera Therapeutics.

  1. K9531-3107 — Phase 3

    Clinical update
  2. K9531-3104 — Phase 3

    Clinical update
  3. K9531-3103 — Phase 3

    Clinical update
  4. KAI-9531 — Phase 3

    Clinical update
  5. KAI-9531 — Phase 3

    Clinical update
  6. KAI-7535 — Phase 2

    Clinical update
  7. KAI-9531 — Phase 1

    Clinical update

Trial registry

10 studies